Table 2.
Pregnancy outcomes before and during the COVID-19 pandemic
| Prevalence of outcomes (%) | Pre-COVID-19 (%) | COVID-19 (%) | χ2 | P value |
| Adverse maternal outcomes | ||||
| Gestational diabetes* | 1262 (27.99) | 872 (27.38) | 0.347 | 0.556 |
| Gestational hypertension* | 281 (6.23) | 196 (6.15) | 0.020 | 0.889 |
| Premature rupture of membranes* | 1385 (30.72) | 1070 (33.59) | 7.119 | 0.008 |
| Caesarean section* | 2065 (45.80) | 1534 (48.16) | 4.197 | 0.040 |
| Adverse foetal outcomes | ||||
| Stillbirth | 2 (0.04) | 3 (0.09) | 0.713 | 0.411† |
| Foetal distress* | 527 (11.69) | 418 (13.12) | 3.574 | 0.059 |
| Preterm birth* | 199 (4.41) | 121 (3.80) | 1.767 | 0.184 |
| Low birth weight* | 137 (3.04) | 96 (3.01) | 0.004 | 0.951 |
| Macrosomia* | 304 (6.74) | 213 (6.69) | 0.009 | 0.925 |
*These pregnancy outcomes were all based on the data from 7694 live births.
†Fisher exact test.